173 related articles for article (PubMed ID: 18499731)
21. Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma.
Yang Q; Liu S; Tian Y; Hasan C; Kersey D; Salwen HR; Chlenski A; Perlman EJ; Cohn SL
Cancer Res; 2004 Jul; 64(13):4531-8. PubMed ID: 15231663
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastoma.
Charlet J; Tomari A; Dallosso AR; Szemes M; Kaselova M; Curry TJ; Almutairi B; Etchevers HC; McConville C; Malik KT; Brown KW
Mol Carcinog; 2017 Apr; 56(4):1290-1301. PubMed ID: 27862318
[TBL] [Abstract][Full Text] [Related]
23. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas.
Hrasćan R; Pećina-Slaus N; Martić TN; Colić JF; Gall-Troselj K; Pavelić K; Karapandza N
J Neuroendocrinol; 2008 Aug; 20(8):1015-22. PubMed ID: 18510707
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells.
Rauschert I; Aldunate F; Preussner J; Arocena-Sutz M; Peraza V; Looso M; Benech JC; Agrelo R
PLoS One; 2017; 12(4):e0175953. PubMed ID: 28422997
[TBL] [Abstract][Full Text] [Related]
25. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights.
Gómez S; Castellano G; Mayol G; Suñol M; Queiros A; Bibikova M; Nazor KL; Loring JF; Lemos I; Rodríguez E; de Torres C; Mora J; Martín-Subero JI; Lavarino C
Epigenomics; 2015 Oct; 7(7):1137-53. PubMed ID: 26067621
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
28. Deletion analysis of the p16 tumour suppressor gene in phaeochromocytomas.
Aguiar RC; Dahia PL; Sill H; Toledo SP; Goldman JM; Cross NC
Clin Endocrinol (Oxf); 1996 Jul; 45(1):93-6. PubMed ID: 8796144
[TBL] [Abstract][Full Text] [Related]
29. Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
Kamimatsuse A; Matsuura K; Moriya S; Fukuba I; Yamaoka H; Fukuda E; Kamei N; Hiyama K; Sueda T; Hiyama E
Pediatr Blood Cancer; 2009 Jul; 52(7):777-83. PubMed ID: 19260109
[TBL] [Abstract][Full Text] [Related]
30. Aberrant methylation of candidate tumor suppressor genes in neuroblastoma.
Hoebeeck J; Michels E; Pattyn F; Combaret V; Vermeulen J; Yigit N; Hoyoux C; Laureys G; De Paepe A; Speleman F; Vandesompele J
Cancer Lett; 2009 Jan; 273(2):336-46. PubMed ID: 18819746
[TBL] [Abstract][Full Text] [Related]
31. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
32. Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior.
Geli J; Kiss N; Karimi M; Lee JJ; Bäckdahl M; Ekström TJ; Larsson C
Clin Cancer Res; 2008 May; 14(9):2551-9. PubMed ID: 18451216
[TBL] [Abstract][Full Text] [Related]
33. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
[TBL] [Abstract][Full Text] [Related]
34. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
[TBL] [Abstract][Full Text] [Related]
35. Integrative epigenomic and genomic analysis of malignant pheochromocytoma.
Sandgren J; Andersson R; Rada-Iglesias A; Enroth S; Akerstrom G; Dumanski JP; Komorowski J; Westin G; Wadelius C
Exp Mol Med; 2010 Jul; 42(7):484-502. PubMed ID: 20534969
[TBL] [Abstract][Full Text] [Related]
36. Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 41 cases investigated in a single endocrine centre.
Patócs A; Karádi E; Tóth M; Varga I; Szücs N; Balogh K; Majnik J; Gláz E; Rácz K
Eur J Cancer Prev; 2004 Oct; 13(5):403-9. PubMed ID: 15452453
[TBL] [Abstract][Full Text] [Related]
37. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
Yang Q; Zage P; Kagan D; Tian Y; Seshadri R; Salwen HR; Liu S; Chlenski A; Cohn SL
Clin Cancer Res; 2004 Dec; 10(24):8493-500. PubMed ID: 15623630
[TBL] [Abstract][Full Text] [Related]
38. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
40. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q
Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
